QR-Code

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

Background The coronavirus disease 2019 (COVID‐19) has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock (J‐SSCG) 2020 Special Committee created the Japanese rapid/living recommendati...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Kazuma Yamakawa, Ryo Yamamoto, Takero Terayama, Hideki Hashimoto, Tadashi Ishihara, Go Ishimaru, Haruki Imura, Hiromu Okano, Chihiro Narita, Takuya Mayumi, Hideto Yasuda, Kohei Yamada, Hiroyuki Yamada, Tatsuya Kawasaki, Nobuaki Shime, Kent Doi, Moritoki Egi, Hiroshi Ogura, Morio Aihara, Shigeki Kushimoto, Osamu Nishida, Special Committee of the Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020), the COVID‐19 Task Force
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2021-01-01
Schriftenreihe:Acute Medicine & Surgery
Schlagworte:
Coronavirus
evidence‐based medicine
GRADE approach
practice guideline
SARS‐CoV‐2
Online-Zugang:https://doi.org/10.1002/ams2.706
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge